Document Detail


Initial experience with tadalafil in pediatric pulmonary arterial hypertension.
MedLine Citation:
PMID:  22402804     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study aimed to investigate the safety, tolerability, and effects of tadalafil on children with pulmonary arterial hypertension (PAH) after transition from sildenafil or after tadalafil received as initial therapy. A total of 33 pediatric patients with PAH were retrospectively evaluated. Of the 33 patients, 29 were switched from sildenafil to tadalafil. The main reason for the change from sildenafil was once-daily dosing. The average dose of sildenafil was 3.4 ± 1.1 mg/kg/day, and that of tadalafil was 1.0 ± 0.4 mg/kg/day. For 14 of the 29 patients undergoing repeat catheterization, statistically significant improvements were observed after transition from sildenafil to tadalafil in terms of mean pulmonary arterial pressure (53.2 ± 18.3 vs. 47.4 ± 13.7 mmHg; p < 0.05) and pulmonary vascular resistance index (12.2 ± 7.0 vs 10.6 ± 7.2 Units/m(2); p < 0.05). Clinical improvement was noted for four patients treated with tadalafil as initial therapy. The side effect profiles were similar for the patients who had transitioned from sildenafil to tadalafil including headache, nausea, myalgia, nasal congestion, flushing, and allergic reaction. Two patients discontinued tadalafil due to migraine or allergic reaction. One patient receiving sildenafil had no breakthrough syncope after transition to tadalafil. Tadalafil can be safely used for pediatric patients with PAH and may prevent disease progression.
Authors:
Shinichi Takatsuki; Michelle Calderbank; David Dunbar Ivy
Related Documents :
17451704 - Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative ...
21221594 - Prospective evaluation of free radicals and antioxidant activity following 6-month rise...
14564634 - Immune thrombocytopenic purpura in patients with ulcerative colitis.
7427044 - Proctocolectomy with ileal reservoir and anal anastomosis.
23195144 - Association among posture, lung function and functional capacity in cystic fibrosis.
21952994 - Iga nephropathy in patients with spondyloarthritis followed-up at the rheumatology serv...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-03-09
Journal Detail:
Title:  Pediatric cardiology     Volume:  33     ISSN:  1432-1971     ISO Abbreviation:  Pediatr Cardiol     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-24     Completed Date:  2012-10-24     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  8003849     Medline TA:  Pediatr Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  683-8     Citation Subset:  IM    
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital Colorado University of Colorado School of Medicine, 13123 East 16th Avenue, B100, Aurora, CO 80045, USA. tekeshin0621@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Carbolines / administration & dosage,  adverse effects,  therapeutic use*
Cardiac Output
Child
Child, Preschool
Disease Progression
Enzyme-Linked Immunosorbent Assay
Female
Humans
Hypertension, Pulmonary / drug therapy*
Male
Phosphodiesterase 5 Inhibitors / administration & dosage,  adverse effects,  therapeutic use*
Piperazines / therapeutic use
Purines / therapeutic use
Retrospective Studies
Statistics, Nonparametric
Sulfones / therapeutic use
Treatment Outcome
Vascular Resistance / drug effects
Grant Support
ID/Acronym/Agency:
P50 HL084923/HL/NHLBI NIH HHS; P50 HL084923-05S1/HL/NHLBI NIH HHS; UL1 RR025780/RR/NCRR NIH HHS; UL1 RR025780/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Carbolines; 0/Phosphodiesterase 5 Inhibitors; 0/Piperazines; 0/Purines; 0/Sulfones; 0/tadalafil; 3M7OB98Y7H/sildenafil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kidney function can improve in patients with hypertensive CKD.
Next Document:  Catheter Interventional Closure of a Large Right Pulmonary Artery-to-Left Atrial Communication in a ...